Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
All content for NHS Specialist Pharmacy Service is the property of NHS Specialist Pharmacy Service and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
Kieran Reynolds talks to Arron Jones, Lead Hepatology Pharmacist about metabolic dysfunction associated steatotic liver disease (MASLD). Discussion includes what MASLD/MASH stands for, prevalence, diagnosis, treatment; including advice to give to patients accessing GLP-1 RAs online, and emerging therapies.
Arron Jones - Lead Hepatology Pharmacist, Bart’s Health Trust
Kieran Reynolds - Advanced Specialist Pharmacist (Medicines Governance), SPS
Useful links:
The British Liver Trust’s information on MASLD, NAFLD and fatty liver disease
https://britishlivertrust.org.uk/information-and-support/liver-conditions/masld-nafld-and-fatty-liver-disease/
The NHS Eatwell Guide
https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/the-eatwell-guide/
The South Asian Eatwell Guide
https://mynutriweb.com/the-south-asian-eatwell-guide/
SPS article on using statins in liver impairment
https://www.sps.nhs.uk/articles/using-statins-in-liver-impairment/
The General Pharmaceutical Council’s FAQs on weight loss medications (including a guide for patients on how to keep safe when getting medicines or treatment online: scroll to bottom of page to access)
https://www.pharmacyregulation.org/patients-and-public/standards-you-can-expect-using-pharmacy-services/weight-loss-medications-faq
NHS Specialist Pharmacy Service
Penny Daynes, Associate Regional Pharmacy procurement specialist at SPS, presents a summary of the resources published by SPS between 1st and 7th November.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
The licence and supporting evidence for ranibizumab biosimilars
Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-ranibizumab-biosimilar/
Preparing to use ranibizumab biosimilar
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
https://www.sps.nhs.uk/articles/preparing-to-use-ranibizumab-biosimilar/
Restricted to NHS: The licence and supporting evidence for aflibercept biosimilars (log in required)
Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/
New Medicines News
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
https://www.sps.nhs.uk/articles/new-medicines-news/
Medicines Governance Do Once (MGDO) programme opportunity
Contact jo.jenkins2@nhs.net for more information. Closing date for applications 30 November 2025.
Next events
Forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Join our new WhatsApp channel to stay up to date with our latest news and updates
https://whatsapp.com/channel/0029VbBslvuJpe8aH3n7Zu1i
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
